Skip to main content
SpringerLink
Log in

The healthcare burden associated with seborrhoeic dermatitis is signficantly greater than that among patients without the disease,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Fowler J, Duh MS, Lobo F, Kosicki G.The direct and indirect cost burden associated with seborrheic dermatitis. Journal of the American Academy of Dermatology 56 (Suppl. 2): 106, No. 2, Feb 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The healthcare burden associated with seborrhoeic dermatitis is signficantly greater than that among patients without the disease,. Pharmacoecon. Outcomes News 524, 11 (2007). https://doi.org/10.2165/00151234-200705240-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705240-00028

Keywords

Search

Navigation